Brenda F. Kurland
Ph.D., University of Washington, Biostatistics, 2002.
M.S., University of Washington, Biostatistics, 2000.
Ed.M., Harvard University, Human Development and Psychology, 1994.
B.A., Harvard/Radcliffe College, Psychology, 1992.
My research emphasis is the design and analysis of cancer clinical trials incorporating quantitative imaging. Quantitative imaging as a cancer biomarker involves several challenges and opportunities that are different from those for tissue and blood biomarkers. Through collaborations with the Quantitative Imaging Network and other multidisciplinary, multi-institutional organizations, I am working on development of imaging biomarkers with respect to reproducibility and optimal trial design. Additionally, I am co-director of the FHCRC Breast SPORE with Dr. Li Hsu and collaborate on many clinical trials in the UW/FHCRC Cancer Consortium.
Throughout my graduate study in education research and biostatistics, my area of emphasis was analysis of longitudinal and other correlated data. I have continued involvement in that area through the Chronic Graft-versus-Host Disease Consortium (PI Dr. Stephanie Lee), and through independent research (funded by Safeway) in between-patient and within-patient (site-to-site) variability in estrogen receptor binding, measured in vivo by FES PET.
American Statistical Association
Caucus for Women in Statistics
International Biometric Society (WNAR)
Society for Clinical Trials
American Association for Cancer Research
Honors and Awards
2002, Senior Biostatistics Student Award, University of Washington
1996-2001, Predoctoral Training Grant (T32), NHLBI
1996-1999, Achievement Rewards for College Scientists Fellowship, University of Washington
1987, National Merit Scholarship, Harvard/Radcliffe College
2006-2012, Assistant Member, Fred Hutchinson Cancer Research Center, Clinical Research Division, Clinical Statistics
2003-2005, Senior Fellow, University of Washington, School of Public Health and Community Medicine, Epidemiology